ContactISSN:e-ISSN: 2757-976X
Author Sign-inReviewer Sign-inRegister
TürkçeEnglish
Home
About Journal
Copyright NoticeOpen Access PolicyAim and ScopePrinciples of ArbitrationReviewer and Editor GuideFee PolicyEthical Principles and Publication PolicyArchiving PolicyIndexing
Information For AuthorsEditorial BoardSend ArticleLatest IssueArchiveContact Us

A Retrospective Evaluation of the Sociodemographic and Clinical Characteristics of Placenta Previa and Placenta Accreta Spectrum Cases Between 2021 and 2023

BERKAN SAYAL,Sinem Tuzcuoglu,Orkun Han,Durmus Onder,Erzat Toprak,Zeynep İnal,HASAN ALİ İNAL

  • BERKAN SAYAL: NECMETTİN ERBAKAN ÜNİVERSİTESİ
  • Sinem Tuzcuoglu: KEPEZ DEVLET HASTANESİ
  • Zeynep İnal: Konya Şehir Hastanesi
  • HASAN ALİ İNAL: KONYA ŞEHİR HASTANESİ
  •  Year : 2024
  •  Vol : 4
  •  Issue : 2
  •  Page : 67-73
Aim: In this study, we aimed to evaluate the demographic characteristics and maternal and perinatal outcomes of placenta previa and PAS cases in our clinic over a three period.
Methods: The sociodemographic characteristics and laboratory results of 94 participants (control = group 1; n=30, placenta previa = group 2; n=44, and PAS = group 3; n=20) were documented and compared between the groups.
Results: Gravity, parity, previous cesarean sections, symptoms on admission, signs of invasion at ultrasonography, gestational age at delivery, birthweight, neonatal intensive care unit admission rate, hysterectomy rate, length of hospital stay, blood transfusion, and atony differed significantly between the groups (p<0.05). Additionally, postoperative hemoglobin (groups 1 vs 2, 10.96+1.78 vs 9.66+1.22; p<0.001 and groups 1 vs 3, 10.96+1.78 vs 9.37+1.20; p<0.001) and Htc (groups 1 vs 2, 32.23±2.84 vs 28.83±3.97; p=0.001 and groups 1 vs 3, 32.23±2.84 vs 28.36±3.49; p<0.001) levels differed between them.
Conclusions: Invasion status and timing of delivery should be determined by means of ultrasonography in cases of placenta previa and PAS. A multidisciplinary approach to pregnant women with PAS in tertiary centers and involving an experienced team is very important in reducing maternal morbidity and mortality rates.
Cite this Article As : Sayal HB, Tuzcuoglu S, Onder D, Han O, Toprak E, Ozturk Inal Z, Inal HA. A Retrospective Evaluation of the Sociodemographic and Clinical Characteristics of Placenta Previa and Placenta Accreta Spectrum Cases Between 2021 and 2023. Mev Med Sci. 2024; 4(2): 67-73

Conflict of interest : The authors declare that they have no conflict of interest.

This article is published under the CC BY-NC 4.0 license.
Mevlana Tıp Bilimleri
2024, Vol4, Issue2
E-ISSN: 2757-976X
Received : , Accepted : , Published Online :

References

  1. 1. Horng HC, Lai MJ, Chang WH, Wang PH. Placenta accreta spectrum (PAS) and peripartum hysterectomy. Taiwan J Obstet Gynecol. 2021;60:395-6.
  2. 2. Tsui KH, Wang PH. Blockage of uterine-feeding vessels: a real choice to maintain the uterus? J Chin Med Assoc. 2011;74:285-6.
  3. 3. Inal ZO, Inal HA, Gorkem U. Sexual function and depressive symptoms in primary infertile women with vitamin D deficiency undergoing IVF treatment. Taiwan J Obstet Gynecol. 2020;59:91-8.
  4. 4. Inal ZO, Inal HA, Kucukkendirci H, Oruc AS. Investigation of Cesarean Sections at Konya Training and Research Hospital Obstetrics and Gynecology Department between 2010 and 2015. Ginekologia Polska 2017;88:185–90.
  5. 5. Inal ZO, Gorkem U, Inal HA. Effects of Preoperative Anxiety on Postcesarean Delivery Pain and Analgesic Consumption: General versus Spinal Anesthesia. J Matern Fetal Neonatal Med. 2020;33:191-97.
  6. 6. Jauniaux E, Chantraine F, Silver RM, Langhoff-Roos J; FIGO Placenta Accreta Diagnosis and Management Expert Consensus Panel. FIGO consensus guidelines on placenta accreta spectrum disorders: Epidemiology. Int J Gynaecol Obstet. 2018;140:265-73.
  7. 7. Balayla J, Bondarenko HD. PAS disorders and the risk of adverse maternal and neonatal outcomes. J Perinat Med. 2013;41:141–9.
  8. 8. Cresswell JA, Ronsmans C, Calvert C, Filippi V. Prevalence of placenta praevia by world region: a systematic review and meta-analysis. Trop Med Int Health. 2013;18:712-24.
  9. 9. Teixidor Viñas M, Belli AM, Arulkumaran S, Chandraharan E. Prevention of postpartum hemorrhage and hysterectomy in patients with morbidly adherent placenta: a cohort study comparing outcomes before and after introduction of the triple-P procedure. Ultrasound Obstet Gynecol. 2015;46:350–5.
  10. 10. Sentilhes L, Goffinet F, Kayem G. Management of PAS disorders. Acta Obstet Gynecol Scand. 2013;92:1125–34.
  11. 11. Wenham J, Matijevic R. Post-partum hysterectomies: revisited. J Perinat Med. 2001;29:260-5.
  12. 12. Hawkins JL. Obstetric Hemorrhage. Anesthesiol Clin. 2020;38:839-58.
  13. 13. Creanga AA, Syverson C, Seed K, Callaghan WM. Pregnancy-Related Mortality in the United States, 2011-2013. Obstet Gynecol. 2017;130:366-73.
  14. 14. Silver RM. Abnormal Placentation: Placenta Previa, Vasa Previa, and Placenta Accreta. Obstet Gynecol. 2015;126:654-68.
  15. 15. Soyer P, Morel O, Tsatsaris V, Bourgioti C, Barat M. Placenta Accreta Spectrum: A Continuously Evolving Challenge for Radiologists. Can Assoc Radiol J. 2021;72:597-8.
  16. 16. Tinari S, Buca D, Cali G, Timor-Tritsch I, Palacios-Jaraquemada J, Rizzo G, et al. Risk factors, histopathology and diagnostic accuracy in posterior placenta accreta spectrum disorders: systematic review and meta-analysis. Ultrasound Obstet Gynecol. 2021;57:903-9.
  17. 17. Eller AG, Bennett MA, Sharshiner M, Masheter C, Soisson AP, Dodson M, et al. Maternal morbidity in cases of PAS disorders managed by a multidisciplinary care team compared with standard obstetric care. Obstet Gynecol. 2011;117:331–7.
  18. 18. Alanwar A, Al-Sayed HM, Ibrahim AM, Elkotb AM, Abdelshafy A, Abdelhadi R, et al. Urinary tract injuries during cesarean section in patients with morbid placental adherence: retrospective cohort study. J Maternal Fetal Neonat Med. 2018;32:1461–67.
  19. 19. van Beekhuizen HJ, Stefanovic V, Schwickert A, Henrich W, Fox KA, MHallem Gziri M, et al; International Society of Placenta Accreta Spectrum (IS-PAS) group. A multicenter observational survey of management strategies in 442 pregnancies with suspected placenta accreta spectrum. Acta Obstet Gynecol Scand. 2021 Mar;100 Suppl 1(Suppl 1):12-20.
  20. 20. Shamshirsaz AA, Fox KA, Salmanian B, Diaz-Arrastia CR, Lee W, Baker BW, et al. Maternal morbidity in patients with morbidly adherent placenta treated with and without a standardized multidisciplinary approach. Am J Obstet Gynecol. 2015;212:218.e1-9.
  21. 21. Jauniaux E, Hussein AM, Fox KA, Collins SL. New evidence-based diagnostic and management strategies for placenta accreta spectrum disorders. Best Pract Res Clin Obstet Gynaecol. 2019;61:75-88.
  22. 22. Henrich W, Surbek D, Kainer F, Grottke O, Hopp H, Kiesewetter H, et al. Diagnosis and treatment of peripartum bleeding. J Perinat Med. 2008;36:467-78.
  23. 23. Demirci O, Tuğrul AS, Yilmaz E, Tosun Ö, Demirci E, Eren YS. Emergency peripartum hysterectomy in a tertiary obstetric center: nine years evaluation. J Obstet Gynaecol Res. 2011;37:1054-60.
  24. 24. American College of Obstetricians and Gynecologists, Society for Maternal - Fetal Medicine. Obstetric Care Consensus No. 7: Placenta Accreta Spectrum. Obstet Gynecol 2018;132:e259.
  25. 25. Eller AG, Porter TF, Soisson P, Silver RM. Optimal management strategies for placenta accreta. BJOG 2009; 116:648.
  26. 26. Shamshirsaz AA, Fox KA, Salmanian B, Diaz-Arrastia CR, Lee W, Baker BW, et al. Maternal morbidity in patients with morbidly adherent placenta treated with and without a standardized multidisciplinary approach. Am J Obstet Gynecol 2015; 212:218.e1.
  27. 27. Scaglione MA, Allshouse AA, Canfield DR, Mclaughlin HD, Bruno AM, Hammad IA, et al. Prophylactic Ureteral Stent Placement and Urinary Injury During Hysterectomy for Placenta Accreta Spectrum. Obstet Gynecol. 2022;140:806-11.
  28. 28. Collins SL, Alemdar B, van Beekhuizen HJ, Bertholdt C, Braun T, Calda P, et al. Evidence-based guidelines for the management of abnormally invasive placenta: recommendations from the International Society for Abnormally Invasive Placenta. Am J Obstet Gynecol. 2019;220:511-26.
  29. 29. Tikkanen M, Paavonen J, Loukovaara M, Stefanovic V. Antenatal diagnosis of placenta accreta leads to reduced blood loss. Acta Obstet Gynecol Scand. 2011;90(10):1140-6.